You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

lapatinib ditosylate

Showing 1 - 25 of 273
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +6 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Los Angeles, California
  • +11 more
Jul 1, 2022

Breast Cancer, Cardiac Toxicity Trial in Rochester (biological, drug, genetic, other, procedure)

Completed
Has Results
  • Breast Cancer
  • Cardiac Toxicity
  • trastuzumab
  • +11 more
  • Rochester, Minnesota
    Mayo Clinic Cancer Research Consortium
Jul 12, 2022

HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer Trial in Los Angeles (drug, biological, other)

Terminated
  • HER2-positive Breast Cancer
  • +2 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Aug 22, 2021

Breast Cancer Trial in Los Angeles (trastuzumab, lapatinib ditosylate)

Completed
  • Breast Cancer
  • trastuzumab
  • lapatinib ditosylate
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
Jul 30, 2020

HER2-Positive Breast Carcinoma, Invasive Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in Canada, Korea,

Completed
Has Results
  • HER2-Positive Breast Carcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +301 more
Jun 28, 2022

Head Neck Cancer, Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous

Completed
Has Results
  • Head and Neck Cancer
  • +19 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Mar 6, 2020

Breast Cancer Trial in United States (lapatinib ditosylate, paclitaxel albumin-stabilized nanoparticle formulation)

Completed
Has Results
  • Breast Cancer
  • lapatinib ditosylate
  • paclitaxel albumin-stabilized nanoparticle formulation
  • Chicago, Illinois
  • +4 more
Feb 24, 2020

CNS Metastases, HER2-positive Breast Cancer, Male Breast Cancer Trial in Los Angeles (lapatinib ditosylate, everolimus,

Completed
  • Central Nervous System Metastases
  • +4 more
  • lapatinib ditosylate
  • +3 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Nov 8, 2019

Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (lapatinib ditosylate, laboratory

Completed
Has Results
  • Primary Peritoneal Cavity Cancer
  • Recurrent Ovarian Epithelial Cancer
  • lapatinib ditosylate
  • laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

HER2/Neu Positive, Invasive Breast Carcinoma, Recurrent Breast Carcinoma Trial in Houston (drug, other, biological)

Completed
  • HER2/Neu Positive
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
May 17, 2019

Breast Cancer Trial in Worldwide (trastuzumab, docetaxel, lapatinib ditosylate)

Active, not recruiting
Has Results
  • Breast Cancer
  • trastuzumab
  • +3 more
  • Anchorage, Alaska
  • +257 more
Feb 28, 2022

Male Breast Carcinoma, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7 Trial in Puerto Rico,

Active, not recruiting
Has Results
  • Male Breast Carcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Tucson, Arizona
  • +317 more
Mar 1, 2022

Tumors, Breast Trial in China, Hong Kong (lapatinib, capecitabine)

Terminated
Has Results
  • Neoplasms, Breast
  • Guangzhou, Guangdong, China
  • +10 more
Aug 26, 2021

HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage IIIB Breast Cancer AJCC v7 Trial in United States (drug,

Completed
Has Results
  • HER2 Positive Breast Carcinoma
  • +4 more
  • Mobile, Alabama
  • +389 more
Mar 11, 2020

Breast Cancer Trial in Manchester (biological, drug, other, procedure)

Active, not recruiting
  • Breast Cancer
  • trastuzumab
  • +5 more
  • Manchester, England, United Kingdom
    Wythenshawe Hospital
Sep 13, 2018

HER2-positive Advanced Breast Cancer Trial in China (BAT8001 for injection, Lapatinib, Capecitabine)

Unknown status
  • HER2-positive Advanced Breast Cancer
  • BAT8001 for injection
  • +2 more
  • Bengbu, Anhui, China
  • +50 more
Dec 1, 2019

Prostate Cancer Trial in Boston (ketoconazole, hydrocortisone, dutasteride)

Terminated
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Aug 29, 2018

Ductal Breast Carcinoma In Situ, HER2/Neu Positive Trial in Birmingham, Houston (Laboratory Biomarker Analysis, Lapatinib

Completed
Has Results
  • Ductal Breast Carcinoma In Situ
  • HER2/Neu Positive
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +1 more
Mar 21, 2018

Recurrent Bladder Cancer, Stage III Bladder Cancer, Stage IV Bladder Cancer Trial in Los Angeles (drug, other, genetic)

Terminated
  • Recurrent Bladder Cancer
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
May 10, 2018

Head Neck Cancer Trial in Brussels (drug, genetic, other, procedure, radiation)

Completed
  • Head and Neck Cancer
  • Brussels, Belgium
    Institut Jules Bordet
Jul 6, 2018

Glioma, Brain Tumor, Glioblastoma Multiforme Trial run by the NCI (lapatinib ditosylate, Adjuvant therapy, Conventional surgery)

Completed
  • Glioma
  • +5 more
  • lapatinib ditosylate
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 3, 2018

Breast Cancer Trial in United States (trastuzumab, carboplatin, docetaxel)

Completed
Has Results
  • Breast Cancer
  • trastuzumab
  • +3 more
  • Scottsdale, Arizona
  • +135 more
Oct 4, 2019

Pyrotinib Plus Vinorelbine Versus Lapatinib Plus Capecitabine

Completed
  • Breast Cancer
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Jun 30, 2022

    Ovarian Cancer Trial in Lexington (Lapatinib and Paclitaxel)

    Recruiting
    • Ovarian Cancer
    • Lapatinib and Paclitaxel
    • Lexington, Kentucky
      Markey Cancer Center
    Dec 2, 2022

    Cancer Trial in Jinan (Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs))

    Recruiting
    • Cancer
    • Busulfan, Paclitaxel, Afatinib, Ceritinib, Crizotinib (Antineoplastic drugs)
    • Jinan, Shandong, China
      Shandong Provincial Qianfoshan Hospital
    Jul 18, 2022